Literature DB >> 7519123

Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.

T Asplund1, P Heldin.   

Abstract

Hyaluronan-binding sites were demonstrated on the cell surface of three malignant mesothelioma cell lines derived from human tumors using either [3H]hyaluronan or fluorescein-tagged hyaluronan. No hyaluronan-binding activity was observed on normal human mesothelial cells. The absence of hyaluronan receptors on normal human mesothelial cells was not due to a down-regulation by endogenously synthesized hyaluronan, since no binding sites appeared when the cells were cultured under conditions known to suppress hyaluronan synthesis (in starvation medium containing either hydrocortisone or n-butyrate) or to degrade endogenously synthesized hyaluronan (in the presence of Streptomyces or testicular hyaluronidase). The binding of [3H]hyaluronan on mesothelioma cells could be partially inhibited by prior incubation of the cells with trypsin, indicating that the hyaluronan-binding site is a protein. The binding sites on human malignant mesothelioma cells were shown to be saturable with about 54,000 hyaluronan molecules (M(r) 1.4 x 10(6)) bound per cell with a Kd of 0.3 x 10(-9) M. The binding was specific for hyaluronan inasmuch as a number of other macromolecules gave negligible inhibition of the binding. High molecular weight preparations of hyaluronan inhibited the binding more effectively than low molecular weight preparations; hyaluronan oligosaccharides down to a length of six monosaccharide units showed competing activity. The hyaluronan receptor appeared to be related to CD44 (a cell surface glycoprotein previously suggested to function as a hyaluronan receptor) since Hermes-1 monoclonal antibodies which inhibit the binding of hyaluronan to CD44 blocked a major part of the binding of hyaluronan to the mesothelioma cells. However, there was no strict correlation between the hyaluronan-binding activity on the mesothelioma cell lines tested and the levels of CD44 molecules on their cell surface, suggesting that only a subfraction of the CD44 molecules bound hyaluronan or that other hyaluronan-binding proteins also exist on those cells. The presence of hyaluronan receptors on mesothelioma cells, but not on their normal counterparts, may be of importance for the migration of the transformed cells in hyaluronan-enriched matrices and for their ability to form metastases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519123

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma.

Authors:  N Guriec; L Marcellin; B Gairard; H Caldéroli; A Wilk; R Renaud; J P Bergerat; F Oberling
Journal:  Clin Exp Metastasis       Date:  1996-10       Impact factor: 5.150

2.  Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship.

Authors:  A Syrokou; G Tzanakakis; T Tsegenidis; A Hjerpe; N K Karamanos
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

3.  Expression of human hyaluronan synthases in response to external stimuli.

Authors:  A Jacobson; J Brinck; M J Briskin; A P Spicer; P Heldin
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

4.  Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer.

Authors:  Shuang Cai; Sharadvi Thati; Taryn R Bagby; Hassam-Mustafa Diab; Neal M Davies; Mark S Cohen; M Laird Forrest
Journal:  J Control Release       Date:  2010-04-18       Impact factor: 9.776

5.  A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo.

Authors:  Mark S Cohen; Shuang Cai; Yumei Xie; M Laird Forrest
Journal:  Am J Surg       Date:  2009-12       Impact factor: 2.565

6.  Nucleolin: acharan sulfate-binding protein on the surface of cancer cells.

Authors:  Eun Ji Joo; Gerdy B ten Dam; Toin H van Kuppevelt; Toshihiko Toida; Robert J Linhardt; Yeong Shik Kim
Journal:  Glycobiology       Date:  2004-08-25       Impact factor: 4.313

Review 7.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

8.  Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

Authors:  Shuang Cai; Yumei Xie; Taryn R Bagby; Mark S Cohen; M Laird Forrest
Journal:  J Surg Res       Date:  2008-03-26       Impact factor: 2.192

9.  Hyaluronan-positive plasma membrane protrusions exist on mesothelial cells in vivo.

Authors:  Ville Koistinen; Tiina Jokela; Sanna Oikari; Riikka Kärnä; Markku Tammi; Kirsi Rilla
Journal:  Histochem Cell Biol       Date:  2016-01-28       Impact factor: 4.304

10.  Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C.

Authors:  M Suzuki; T Asplund; H Yamashita; C H Heldin; P Heldin
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.